E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 9/10/2021 in the Prospect News High Yield Daily.

Endo rallies on opioid settlement; Mallinckrodt mixed; Envision notes soft; Talen lower

By Cristal Cody

Tupelo, Miss., Sept. 10 – Endo International plc’s bonds rallied over 3 points on Friday following the company’s announcement late Thursday that it settled an opioid-related lawsuit for $50 million.

Endo Finance LLC’s 6% senior notes due 2028 (Caa3/CCC+) climbed to as high as 69½ bid in heavy trading before finishing the session still stronger on the day at 67½ bid, a source said.

The notes traded at 64¼ bid on Thursday.

Other distressed pharmaceutical issuers were active during the session.

Mallinckrodt LLC’s paper traded flat to about ½ point better on Friday.

The 5½% notes due 2025 rose ½ point to 67 bid.

Distressed health care paper was lower over the short holiday week, a source said.

Envision Healthcare Corp.’s 8¾% senior notes due 2026 (Ca/CC) ended the day ½ point weaker after losing 6 points on Wednesday and Thursday.

Bonds in the distressed energy space were mixed in light trading.

Talen Energy Supply LLC’s notes mostly softened on Friday after the paper traded up about 2½ points in the prior session.

Talen’s 6½% senior notes due 2025 (B3/CCC/B-) fell ½ point to 43 bid.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.